Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.9 USD | -2.25% | -7.08% | -51.93% |
Apr. 18 | Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating | MT |
Mar. 26 | 10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay | CI |
Financials (USD)
Sales 2024 * | 678M | Sales 2025 * | 790M | Capitalization | 3.28B |
---|---|---|---|---|---|
Net income 2024 * | -188M | Net income 2025 * | -114M | EV / Sales 2024 * | 4.36 x |
Net cash position 2024 * | 324M | Net cash position 2025 * | 366M | EV / Sales 2025 * | 3.69 x |
P/E ratio 2024 * |
-17
x | P/E ratio 2025 * |
-29.1
x | Employees | 1,259 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.5% |
Latest transcript on 10x Genomics, Inc.
1 day | -2.25% | ||
1 week | -7.08% | ||
Current month | -28.32% | ||
1 month | -25.92% | ||
3 months | -36.56% | ||
6 months | -27.34% | ||
Current year | -51.93% |
Managers | Title | Age | Since |
---|---|---|---|
Serge Saxonov
FOU | Founder | 47 | 12-07-01 |
Ben Hindson
FOU | Founder | 49 | 12-07-01 |
Justin McAnear
DFI | Director of Finance/CFO | 49 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Stuelpnagel
CHM | Chairman | 66 | 13-07-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-03-25 |
Mathai Mammen
BRD | Director/Board Member | 57 | 17-08-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 26.9 | -2.25% | 1,133,262 |
24-04-24 | 27.52 | -0.22% | 1,800,383 |
24-04-23 | 27.58 | -0.79% | 1,991,587 |
24-04-22 | 27.8 | -0.50% | 1,792,088 |
24-04-19 | 27.94 | -3.49% | 2,078,467 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.93% | 3.28B | |
-1.09% | 12.72B | |
-12.53% | 7.5B | |
+0.45% | 5.48B | |
-1.37% | 4.61B | |
+5.16% | 4.47B | |
+11.34% | 2.71B | |
-19.05% | 2.02B | |
-11.07% | 1.74B | |
-6.06% | 1.69B |
- Stock Market
- Equities
- TXG Stock